Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flaviu Bob

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Renal Failure|November 15, 2016
Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot studyAdrian Vlad, Mihaela Vlad, Ligia Petrica, et al.
Biomarkers in Medicine|October 22, 2020
Urinary proteins detected using modern proteomics intervene in early type 2 diabetic kidney disease - a pilot studyAlina Golea-Secara, Cristian Munteanu, Mirela Sarbu, et al.
International Journal of Molecular Sciences|April 17, 2025
Targeted Analysis of Serum and Urinary Metabolites for Early Chronic Kidney DiseaseMihaela-Roxana Glavan, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 28, 2017
Deregulated profiles of urinary microRNAs may explain podocyte injury and proximal tubule dysfunction in normoalbuminuric patients with type 2 diabetes mellitusOana Milas, Florica Gadalean, Adrian Vlad, et al.
Journal of Clinical Medicine|August 29, 2024
Biomarker Profiling with Targeted Metabolomic Analysis of Plasma and Urine Samples in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney DiseaseMaria Mogos, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Biomedicines|May 16, 2023
Untargeted Metabolomics by Ultra-High-Performance Liquid Chromatography Coupled with Electrospray Ionization-Quadrupole-Time of Flight-Mass Spectrometry Analysis Identifies a Specific Metabolomic Profile in Patients with Early Chronic Kidney DiseaseMihaela-Roxana Glavan, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Biomedicines|March 28, 2025
Urinary and Serum Amino Acids May Be Associated with Podocyte, Proximal Tubule, and Renal Endothelial Injury in Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus PatientsMaria Mogos, Oana Milas, Carmen Socaciu, et al.
Angiology|January 21, 2016
Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis PatientsSimona Hogas, Adalbert Schiller, Luminita Voroneanu, et al.
International Journal of Molecular Sciences|June 28, 2023
Mitochondrial DNA Changes in Blood and Urine Display a Specific Signature in Relation to Inflammation in Normoalbuminuric Diabetic Kidney Disease in Type 2 Diabetes Mellitus PatientsLigia Petrica, Adrian Vlad, Florica Gadalean, et al.
International Journal of Molecular Sciences|December 30, 2025
Gut-Derived Metabolomic Biomarkers as Mediators of the Inflammatory Pathway in Early Diabetic Kidney DiseaseLavinia Marcu, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Renal Failure|November 15, 2016
Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot studyAdrian Vlad, Mihaela Vlad, Ligia Petrica, et al.
Biomarkers in Medicine|October 22, 2020
Urinary proteins detected using modern proteomics intervene in early type 2 diabetic kidney disease - a pilot studyAlina Golea-Secara, Cristian Munteanu, Mirela Sarbu, et al.
International Journal of Molecular Sciences|April 17, 2025
Targeted Analysis of Serum and Urinary Metabolites for Early Chronic Kidney DiseaseMihaela-Roxana Glavan, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 28, 2017
Deregulated profiles of urinary microRNAs may explain podocyte injury and proximal tubule dysfunction in normoalbuminuric patients with type 2 diabetes mellitusOana Milas, Florica Gadalean, Adrian Vlad, et al.
Journal of Clinical Medicine|August 29, 2024
Biomarker Profiling with Targeted Metabolomic Analysis of Plasma and Urine Samples in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney DiseaseMaria Mogos, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Biomedicines|May 16, 2023
Untargeted Metabolomics by Ultra-High-Performance Liquid Chromatography Coupled with Electrospray Ionization-Quadrupole-Time of Flight-Mass Spectrometry Analysis Identifies a Specific Metabolomic Profile in Patients with Early Chronic Kidney DiseaseMihaela-Roxana Glavan, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Biomedicines|March 28, 2025
Urinary and Serum Amino Acids May Be Associated with Podocyte, Proximal Tubule, and Renal Endothelial Injury in Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus PatientsMaria Mogos, Oana Milas, Carmen Socaciu, et al.
Angiology|January 21, 2016
Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis PatientsSimona Hogas, Adalbert Schiller, Luminita Voroneanu, et al.
International Journal of Molecular Sciences|June 28, 2023
Mitochondrial DNA Changes in Blood and Urine Display a Specific Signature in Relation to Inflammation in Normoalbuminuric Diabetic Kidney Disease in Type 2 Diabetes Mellitus PatientsLigia Petrica, Adrian Vlad, Florica Gadalean, et al.
International Journal of Molecular Sciences|December 30, 2025
Gut-Derived Metabolomic Biomarkers as Mediators of the Inflammatory Pathway in Early Diabetic Kidney DiseaseLavinia Marcu, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Pageof 9